dr. ronald farcas criticized the effectiveness, resulting in the fda delaying its decision on that medicinethere is currently no approved treatment for the disea shares soared 26% to 32.45. all allergan will have a deal that will expand the portfolio of dermatology appointments. up 2% on the day at 244.81. the real action at veti which saw shares sky rocket. more than doubling to $20.85. going the other way, ruby tuesday said yesterday its ceo stepped down after the restaurant chain's board reportedly called for a resi according to the "wall street jour" the decision was tied to faltering sales and weakness in the dining industry. separately, the coy gave disappointing preliminary results for the current quarter. ruby tuesday down 7.5% to $2.82. >>> cracker barrel saw profit and sales rise as higher menu prices help to lift results. but the restaurant chain issued weaker than expected guidance for not just the current quarter, but also the full year. as a result, shares fell 7% to $139.98. boeing warped it may make additional production cuts to its line of 777 airliners if demand doesn't pi